title: IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.
abstract: The overexpression of IRX1 gene correlates with the growth arrest in gastric cancer. Furthermore, overexpression of IRX1 gene suppresses peritoneal spreading and long distance metastasis. To explore the precise mechanisms, we investigated whether restoring IRX1 expression affects the angiogenesis or vasculogenic mimicry (VM). Human umbilical vein endothelial cells (HUVECs) and chick embryo and SGC-7901 gastric cancer cells were used for angiogenesis and VM analysis. Small interfering RNA was used for analyzing the function of BDKRB2, a downstream target gene of IRX1. As results, the remarkable suppression on peritoneal spreading and pulmonary metastasis of SGC-7901 cells by IRX1 transfectant correlates to reduced angiogenesis as well as VM formation. Using the supernatant from SGC-7901/IRX1 cells, we found a strong inhibiting effect on angiogenesis both in vitro and in chick embryo. SGC-7901/IRX1 cells revealed strong inhibiting effect on VM formation too. By gene-specific RNA interference for BDKRB2, or its effector PAK1, we got an effective inhibition on tube formation, cell proliferation, cell migration and invasion in vitro. In conclusion, enforcing IRX1 expression effectively suppresses peritoneal spreading and pulmonary metastasis via anti-angiogenesis and anti-VM mechanisms, in addition to previously found cell growth and invasion. BDKRB2 and its downstream effector might be potential targets for anti-cancer strategy.
authors: Department of Surgery, Shanghai Ruijin Hospital, China.
authors: J
authors: J
authors: Jiang
authors: W
authors: W
authors: Liu
authors: X
authors: X
authors: Guo
authors: R
authors: R
authors: Zhang
authors: Q
authors: Q
authors: Zhi
authors: J
authors: J
authors: Ji
authors: J
authors: J
authors: Zhang
authors: X
authors: X
authors: Chen
authors: J
authors: J
authors: Li
authors: J
authors: J
authors: Zhang
authors: Q
authors: Q
authors: Gu
authors: B
authors: B
authors: Liu
authors: Z
authors: Z
authors: Zhu
authors: Y
authors: Y
authors: Yu
references: Cancer Res. 2008 Jun 15;68(12):4494-9
references: 18559491
references: Cancer Res. 2005 Dec 15;65(24):11520-8
references: 16357161
references: P R Health Sci J. 2005 Mar;24(1):27-33
references: 15895874
references: Mol Cancer Res. 2008 Dec;6(12):1946-56
references: 19074839
references: Cell Signal. 2009 Dec;21(12):1727-37
references: 19720142
references: Cancer Lett. 2007 Sep 8;254(2):157-64
references: 17306454
references: Zhonghua Yi Xue Za Zhi. 2002 Oct 10;82(19):1298-302
references: 12509930
references: Histochem Cell Biol. 2008 Dec;130(6):1119-30
references: 19005674
references: Hum Pathol. 2008 Mar;39(3):444-51
references: 18261629
references: Cancer Res. 2007 Jan 15;67(2):727-34
references: 17234784
references: J Histochem Cytochem. 2005 Aug;53(8):997-1002
references: 15923371
references: Mol Pharmacol. 2010 Jul;78(1):126-34
references: 20385709
references: Prostate. 2002 Feb 15;50(3):189-201
references: 11813211
references: Biomol Eng. 2006 Mar;23(1):17-34
references: 16466964
references: Methods Enzymol. 2008;444:21-41
references: 19007659
references: Int J Oncol. 2004 Dec;25(6):1609-14
references: 15547697
references: Cancer Biol Ther. 2009 Jul;8(14):1360-8
references: 19448398
references: Anticancer Res. 2006 Jan-Feb;26(1A):59-69
references: 16475680
references: J Cell Physiol. 2002 Nov;193(2):133-44
references: 12384990
references: Am J Pathol. 1999 Sep;155(3):739-52
references: 10487832
references: Cancer Res. 2004 Aug 1;64(15):5178-85
references: 15289322
references: Am J Pathol. 2001 Apr;158(4):1279-88
references: 11290546
references: Development. 2008 Oct;135(19):3197-207
references: 18715948
references: Circ Res. 2008 Nov 21;103(11):1335-43
references: 18927465
references: Int J Cancer. 2002 Mar 1;98(1):29-35
references: 11857381
references: Cancer. 2004 Apr 15;100(8):1768-9; author reply 1769
references: 15073872
references: Methods Mol Biol. 2008;442:159-72
references: 18369785
references: Mech Dev. 2001 Aug;106(1-2):155-8
references: 11472847
references: PLoS One. 2010 Jul 15;5(7):e11583
references: 20657647
references: Leukemia. 2009 Jun;23(6):1039-48
references: 19340002
references: Am J Physiol Gastrointest Liver Physiol. 2008 Oct;295(4):G709-17
references: 18669622
references: Oncogene. 2008 Sep 11;27(40):5315-25
references: 18521085
references: Chem Biol. 2006 May;13(5):549-56
references: 16720276
references: J Biol Chem. 2000 Mar 31;275(13):9106-9
references: 10734042
references: Expert Opin Ther Targets. 2010 Apr;14(4):419-33
references: 20146633
references: Cancer Res. 2009 Dec 15;69(24):9301-5
references: 19934318
references: Peptides. 2010 Feb;31(2):238-41
references: 19969036
references: Nucleic Acids Res. 2005 Jun 07;33(10):e92
references: 15942024
references: Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H708-13
references: 18055521
references: Int J Gynecol Cancer. 2008 May-Jun;18(3):476-86
references: 17645504
references: Int Immunopharmacol. 2002 Mar;2(4):499-509
references: 11962729
references: Oncogene. 2010 Jul 8;29(27):3908-20
references: 20440264
references: Int J Cancer. 2009 Dec 1;125(11):2511-9
references: 19610058
references: Oncol Rep. 2006 Oct;16(4):693-8
references: 16969481
references: Breast Cancer Res. 2006;8(6):R69
references: 17156488
references: Cell. 2006 Nov 17;127(4):679-95
references: 17110329
references: Breast Cancer Res. 2003;5(3):136-9
references: 12793894
references: Cancer Lett. 2005 Jun 28;224(2):329-37
references: 15914283
references: Cancer Lett. 2005 Nov 8;229(1):13-23
references: 16157214
references: Cancer Gene Ther. 2000 Apr;7(4):589-96
references: 10811477